Last updated: February 1, 202616 min read

Key Takeaways

  • Spravato (esketamine) is the only form of ketamine commonly covered by insurance -- it is FDA-approved for treatment-resistant depression and major depressive disorder with suicidal ideation
  • Generic ketamine (IV, IM, sublingual) is used off-label and is almost never covered by insurance, even with a letter of medical necessity
  • Prior authorization for Spravato typically requires documented failure of at least 2 antidepressants at adequate dose and duration
  • HSA and FSA funds can be used for any form of prescribed ketamine therapy, effectively providing a 25-35% savings
  • If your Spravato claim is denied, you have the right to appeal -- and appeals succeed in approximately 40-60% of cases

Ketamine Insurance Coverage: What Plans Cover & How to Get Approved

Navigating insurance coverage for ketamine therapy is one of the most confusing aspects of accessing this treatment. The short answer is that most forms of ketamine therapy are not covered by insurance -- but there are important exceptions, workarounds, and strategies that can significantly reduce your out-of-pocket costs.

This guide explains exactly what is and is not covered, how to maximize your insurance benefits, and what alternative payment options exist when insurance falls short.

The Current State of Ketamine Insurance Coverage

The insurance landscape for ketamine therapy can be summarized in one critical distinction: FDA-approved vs. off-label use.

What Insurance Typically Covers

Spravato (esketamine nasal spray) is the only ketamine-based treatment with widespread insurance coverage. Spravato is FDA-approved for two specific indications:

  1. Treatment-resistant depression (TRD) -- Defined as major depressive disorder that has not responded adequately to at least two antidepressant treatments at adequate dose and duration in the current episode
  2. Major depressive disorder with acute suicidal ideation or behavior -- A newer indication approved in 2020

Most major commercial insurance plans, Medicare Part B, and many state Medicaid programs cover Spravato with prior authorization. The Janssen Savings Program can further reduce out-of-pocket costs to as little as $10 per session for commercially insured patients.

What Insurance Does NOT Cover

Generic racemic ketamine used in any form -- IV infusions, IM injections, sublingual tablets, troches, nasal spray, or at-home programs -- is almost never covered by insurance. This is because:

  • Ketamine is FDA-approved only as an anesthetic, not for mental health conditions
  • Its use for depression, anxiety, PTSD, and pain is considered "off-label"
  • Insurance companies generally exclude off-label medication use from coverage
  • There is no standardized dosing protocol that insurers can evaluate

This means the most common and widely available form of ketamine therapy -- IV infusions at specialized clinics -- is an out-of-pocket expense for the vast majority of patients.

Insurance coverage by ketamine treatment form
Treatment FormFDA Status for Mental HealthInsurance CoverageTypical Out-of-Pocket
Spravato (esketamine)FDA-approved for TRDCovered by most plans$10-$150/session (with insurance)
IV Ketamine InfusionOff-labelNot covered$400-$800/session
IM Ketamine InjectionOff-labelNot covered$300-$600/session
Sublingual KetamineOff-labelNot covered$200-$400/month
Compounded Nasal SprayOff-labelNot covered$150-$350/month
Ketamine TrochesOff-labelNot covered$150-$350/month

Insurance Coverage by Provider Type

Major Commercial Insurers

Spravato coverage by major insurance companies (2026)
Insurance CompanySpravato CoveredPrior Auth RequiredNotes
UnitedHealthcareRequires 2 failed antidepressants; step therapy
Blue Cross Blue ShieldVaries by state/plan; some require 3 failed meds
AetnaCovers both TRD and suicidal ideation indications
CignaRequires documented treatment history
HumanaMedicare Advantage plans may have additional criteria
Kaiser PermanenteMay require internal psychiatrist referral
AnthemCovers with standard prior auth process

Important: Even within these companies, coverage varies by specific plan, state, and employer group. Always verify coverage with your specific plan before starting treatment.

Medicare

Medicare Part B covers Spravato when:

  • Administered at a Medicare-certified healthcare facility enrolled in the Spravato REMS program
  • Prior authorization demonstrates treatment-resistant depression
  • The patient has documented failure of at least 2 adequate antidepressant trials
  • The administering provider accepts Medicare assignment

Medicare does NOT cover generic ketamine for mental health indications under any circumstance.

Medicare Advantage plans may have different prior authorization requirements and network restrictions. Some plans may require you to use specific certified treatment centers.

Medicaid

Medicaid coverage for Spravato varies by state. As of 2026, most state Medicaid programs cover Spravato with prior authorization, but approval criteria and the appeals process differ significantly. Some states have more restrictive criteria than commercial insurance, while others are relatively straightforward.

Generic ketamine infusions are not covered by any state Medicaid program for mental health indications.

The Prior Authorization Process

If you are seeking Spravato coverage, prior authorization (PA) is required by virtually all insurance plans. Here is what to expect.

What Your Doctor Needs to Document

  1. DSM-5 diagnosis of major depressive disorder (MDD)
  2. Treatment resistance -- Evidence that at least 2 antidepressant medications (from different classes) were tried at adequate dose and duration without adequate response
  3. Current symptom severity -- Usually measured by PHQ-9 or MADRS scores
  4. Previous treatment history -- Detailed list of all medications, dosages, durations, and reasons for discontinuation
  5. Clinical rationale -- Why Spravato is appropriate for this specific patient

Timeline

  • Submission to decision: 3-14 business days (varies by insurer)
  • Urgent/expedited review: 24-72 hours (for patients with acute suicidal ideation)
  • Appeal timeline: 30-60 days for internal appeal; additional time for external review

Tips for Faster Approval

  • Have your psychiatrist submit complete documentation the first time -- incomplete submissions are the number one reason for delays
  • Include PHQ-9 or MADRS scores from the past 6-12 months showing persistent depression
  • Provide pharmacy records (not just doctor notes) documenting prior medication trials
  • Ask your Spravato clinic if they have a dedicated insurance coordinator -- many do, and they handle hundreds of these authorizations
  • If you have a history of suicidal ideation, ensure this is clearly documented, as it qualifies for the second FDA-approved indication

What to Do If Your Claim Is Denied

Insurance denials for Spravato are common but not final. Here is how to fight back.

Step 1: Understand the Denial Reason

Request the specific reason for denial in writing. Common reasons include:

  • Insufficient documentation of treatment resistance
  • Inadequate trial of oral antidepressants (too short, too low a dose)
  • Missing clinical information
  • Plan exclusion (some employer-sponsored plans carve out Spravato)

Step 2: Internal Appeal

File an internal appeal within the timeframe specified in your denial letter (usually 30-60 days). Include:

  • A letter from your psychiatrist explaining medical necessity
  • Updated documentation addressing the specific denial reason
  • Any additional clinical records, lab results, or therapy notes
  • Published research supporting Spravato for your specific situation

Step 3: External Review

If the internal appeal is denied, you have the right to request an external review by an independent third party. This is a federally mandated right under the ACA for all non-grandfathered plans. External reviewers overturn insurance decisions in a meaningful percentage of cases.

Step 4: Contact Your State Insurance Commissioner

If you believe your claim was wrongfully denied, file a complaint with your state department of insurance. This escalates the review and can result in the insurer being required to cover your treatment.

Strategies for Maximizing Insurance Benefits

Even when ketamine infusions are not directly covered, there are ways to leverage your insurance:

While the ketamine infusion itself may not be covered, some associated services may be:

  • Initial psychiatric evaluation -- Often covered under mental health benefits
  • Lab work and EKG -- Usually covered as diagnostic services
  • Integration therapy sessions -- Covered under psychotherapy benefits
  • Follow-up psychiatric appointments -- Covered under mental health benefits

This can save $500-$1,500+ per year by billing these services through insurance even if the infusion itself is out of pocket.

2. Use Out-of-Network Benefits

Some insurance plans have out-of-network mental health benefits. If your ketamine clinic provides a superbill (detailed receipt with medical codes), you can submit it to your insurer for partial reimbursement. Reimbursement is not guaranteed, but some patients have received 20-50% back.

3. HSA/FSA Accounts

This is the single most effective strategy for reducing the effective cost of out-of-pocket ketamine therapy:

  • HSA (Health Savings Account): Available with high-deductible health plans. Contributions are tax-deductible, growth is tax-free, and withdrawals for qualified medical expenses are tax-free. Triple tax advantage.
  • FSA (Flexible Spending Account): Available with most employer plans. Contributions are pre-tax, reducing your taxable income.

Using pre-tax dollars effectively gives you a 25-35% discount on ketamine therapy (depending on your marginal tax rate).

To use HSA/FSA funds:

  1. Obtain a prescription from a licensed provider
  2. Get a receipt showing the medical service and amount
  3. Keep a letter of medical necessity on file
  4. Pay with your HSA/FSA debit card or submit for reimbursement

4. Combine Spravato with Generic Ketamine

Some patients use insurance-covered Spravato for their primary treatment and supplement with less frequent generic ketamine sessions when needed. This hybrid approach leverages insurance for the bulk of treatment while using out-of-pocket funds only for supplementary sessions.

Looking Ahead: The Future of Ketamine Insurance Coverage

Several developments may expand insurance coverage for ketamine therapy in the coming years:

Pending FDA Applications

Multiple pharmaceutical companies are pursuing FDA approval for ketamine-based compounds beyond Spravato. FDA approval is the single biggest factor in determining insurance coverage, so each new approval could expand access.

State Parity Laws

Mental health parity laws require insurance companies to cover mental health conditions at the same level as physical health conditions. As ketamine therapy becomes more established, advocates are pushing for these laws to be applied more aggressively to ensure coverage of effective treatments.

Employer Advocacy

If you receive insurance through your employer, consider advocating for ketamine therapy coverage to be added to your company's plan. Employers have the power to negotiate plan changes, and the cost-effectiveness argument for treating treatment-resistant conditions is compelling.

Clinical Guidelines

As more professional medical organizations include ketamine therapy in their treatment guidelines (the American Psychiatric Association already acknowledges its evidence base), insurers face increasing pressure to provide coverage.

Practical Next Steps

  1. Check your specific plan: Call the member services number on your insurance card and ask specifically about Spravato coverage and prior authorization requirements
  2. Maximize your HSA/FSA: If you are paying out of pocket, ensure you are using pre-tax dollars whenever possible
  3. Ask your clinic about insurance: Many Spravato-certified clinics have insurance coordinators who can check your benefits for free
  4. Request superbills: Even if not directly covered, submit superbills for possible out-of-network reimbursement
  5. Appeal denials: Never accept the first denial as final -- the appeal process exists for a reason

Understanding your coverage options is a critical step in making ketamine therapy accessible. While the insurance landscape is not ideal for most forms of ketamine treatment, strategic planning can significantly reduce your costs.

For a detailed cost comparison across all treatment types, see our ketamine cost guide. For financing options beyond insurance, explore our payment plans guide.


Insurance coverage information is based on general industry patterns as of early 2026. Individual coverage varies by plan, employer, state, and specific policy terms. Always verify coverage directly with your insurance provider.

Frequently Asked Questions About Insurance Coverage

References

  1. [1]Spravato REMS Program Requirements and Coverage Guidelines FDA / Janssen Pharmaceuticals (2024)
  2. [2]Insurance Coverage Patterns for Ketamine-Based Therapies in Mental Health Psychiatric Services (2023)
  3. [3]Prior Authorization Requirements for Esketamine: A Multi-Payer Analysis Journal of Managed Care & Specialty Pharmacy (2023)
  4. [4]HSA/FSA Eligibility for Off-Label Psychiatric Medications IRS Publication 502 (2025)

Next Steps

Was this article helpful?

Medical Disclaimer: The information on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Ketamine therapy should only be administered by licensed medical professionals in appropriate clinical settings.